The Sickle Cell Anemia Testing Service ecosystem comprises interconnected upstream, midstream, and downstream actors that collectively enable diagnostic delivery. Upstream, reagent manufacturers and instrument OEMs supply the analytical components required for hemoglobin electrophoresis, HPLC, and molecular assays. Midstream participants—laboratory service providers, system integrators, and data analytics firms—assemble the hardware, software, and workflow protocols into accredited testing sites. Downstream, hospitals, clinics, public health programs, and patient advocacy groups consume the test results for clinical decision‑making and population screening. Value is created through the conversion of raw reagents into clinically actionable data, captured by service fees, reimbursements, and health‑system budgeting.